Liraglutide, a synthetic analogue of glucagon-like peptide-1 (GLP-1), represents a prominent subject in peptide research due to its diverse physiological and biochemical properties. Originally designed as a long-acting GLP-1 receptor agonist, Liraglutide is believed to extend its support beyond classical glycemic regulation, offering valuable insights for various scientific research domains. This article examines the molecular […] The post Liraglutide: A Multifaceted Peptide with Expanding ...
